Results 231 to 240 of about 2,695,708 (355)
Antiretroviral Therapy for the Prevention of HIV-1 Transmission.
New England Journal of Medicine, 2016 M. Cohen, Y. Chen, M. McCauley, T. Gamble, M. Hosseinipour, N. Kumarasamy, J. Hakim, J. Kumwenda, B. Grinsztejn, J. Pilotto, S. Godbole, S. Chariyalertsak, B. Santos, K. Mayer, I. Hoffman, S. Eshleman, E. Piwowar-Manning, L. Cottle, X. Zhang, J. Makhema, L. Mills, R. Panchia, Sharlaa Faesen, J. Eron, J. Gallant, D. Havlir, S. Swindells, V. Elharrar, David Burns, T. Taha, K. Nielsen‐Saines, D. Celentano, M. Essex, S. Hudelson, A. Redd, T. Fleming +35 moresemanticscholar +1 more sourceHIV-specific CD8+ T-cell proliferative response 24 weeks after early antiretroviral therapy initiation is associated with the subsequent reduction in the viral reservoir. [PDF]
Elifevan Paassen PM, Pasternak AO, Bolluyt DC, van Dort KA, van Nuenen AC, Maurer I, Boeser-Nunnink B, Buchholtz NVEJ, Mahmoudi T, Lungu C, van Crevel R, Rokx C, Symons J, Nijhuis M, van der Veen ALIP, Vogt L, Klouwens MJ, Prins JM, Kootstra NA, de Bree GJ. +19 moreeuropepmc +1 more sourceSexual Activity Without Condoms and Risk of HIV Transmission in Serodifferent Couples When the HIV-Positive Partner Is Using Suppressive Antiretroviral Therapy.
Journal of the American Medical Association (JAMA), 2016 A. Rodger, V. Cambiano, T. Bruun, P. Vernazza, S. Collins, J. van Lunzen, G. Corbelli, V. Estrada, A. Geretti, Apostolos Beloukas, D. Asboe, P. Viciana, F. Gutiérrez, B. Clotet, C. Pradier, J. Gerstoft, R. Weber, K. Westling, G. Wandeler, J. Prins, A. Rieger, M. Stoeckle, T. Kümmerle, T. Bini, A. Ammassari, R. Gilson, I. Krznaric, M. Ristola, R. Zangerle, Pia Handberg, A. Antela, S. Allan, A. Phillips, J. Lundgren +33 moresemanticscholar +1 more sourceAdvancing Maternal Health with Long‐Acting Therapeutics: Priorities, Efficacy and Safety Considerations, and Emerging Technologies
Clinical Pharmacology &Therapeutics, EarlyView.Maternal health remains a critical global concern, particularly in underserved populations and in low‐ and middle‐income countries where access to safe and effective therapeutics is limited. Despite the use of medications by most women during pregnancy, the exclusion of pregnant and lactating women from clinical trials has resulted in significant data ...Rachel K. Scott, Sharon Nachman, Ethel D. Weld, Rachel Daley, Shakir Atoyebi, Robert Bies, Catriona Waitt, Adeniyi Olagunju +7 morewiley +1 more sourceFamily's socioeconomic and demographic factors on elements of children's dental and oral health: A scoping review
Clinical and Experimental Dental Research, EarlyView.Abstract Background
Family plays a significant role in children's dental and oral health (DOH) elements, such as children's DOH knowledge and practice, the development of children's dental fear and anxiety (DFA), children's dental visits, and children's DOH status.Wisnu Fadila, Mugia B. Rahardja, Puguh Prasetyoputra, Anne A. Suwargiani, Yanu E. Prasetyo, Eriska Riyanti +5 morewiley +1 more sourceEvaluating the safety of prenatal HIV PrEP use: Perinatal outcomes from three cohort studies in Western Kenya. [PDF]
PLOS Glob Public HealthOdhiambo B, Stern J, Kinuthia J, Abuna F, Akim E, Concepcion T, Dettinger JC, Gómez L, Larsen A, Marwa M, Mogaka J, Ngumbau N, Nzove E, Richardson BA, Watoyi S, John-Stewart G, Pintye J. +16 moreeuropepmc +1 more sourceThe β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
Cell, 1996 H. Choe, M. Farzan, Ying Sun, N. Sullivan, B. Rollins, P. Ponath, Lijun Wu, C. Mackay, G. Larosa, W. Newman, N. Gerard, C. Gerard, J. Sodroski +12 moresemanticscholar +1 more source